Synthetic triterpenoids and methods for modulating stem/progenitor cell gene expression
    32.
    发明授权
    Synthetic triterpenoids and methods for modulating stem/progenitor cell gene expression 有权
    合成三萜类化合物和调节干/祖细胞基因表达的方法

    公开(公告)号:US09205113B2

    公开(公告)日:2015-12-08

    申请号:US14395157

    申请日:2013-05-07

    摘要: Synthetic triterpenoids and methods of using the same to induce gene expression and differentiation of stem or progenitor cells are provided. Furthermore, the present invention provides methods for producing a cell, such as a stem or progenitor cell, with induced gene expression by contacting a stem or progenitor cell with an effective amount of a synthetic triterpenoid to induce the expression of one or more of SOX9 (Sex determining region Y-box 9), COL2A1 (Type II Collagen (alpha1)), TGF-βI, TGF-p2, TGF-33, BMP2, BMP4, BMPRII (Bone Morphogenic Protein Receptor II), SMAD (Small Mothers Against Decapentaplegic) 3, SMAD4, SMAD6, SMAD7, TIMP (Tissue Inhibitor of Metalloproteinase)-1 or TIMP-2 in the stem or progenitor cell, wherein the stem or progenitor cell is not a mesenchymal stem cell, periosteium cell or osteoprogenitor cell. In one embodiment, the stem or progenitor cell is multipotent.

    摘要翻译: 提供合成三萜类化合物及其使用方法诱导干细胞或祖细胞的基因表达和分化。 此外,本发明提供了通过使干细胞或祖细胞与有效量的合成三萜化合物接触以诱导一种或多种SOX9的表达来生产具有诱导的基因表达的细胞例如干细胞或祖细胞的方法( 性别确定区域Y盒9),COL2A1(II型胶原(α1)),TGF-和bgr I,TGF-p2,TGF-β3,BMP2,BMP4,BMPRII(骨形态发生蛋白受体II),SMAD 针对剔除性皮炎)3,SMAD4,SMAD6,SMAD7,TIMP(金属蛋白酶组织抑制剂)-1或TIMP-2在茎或​​祖细胞中,其中干细胞或祖细胞不是间充质干细胞,骨膜细胞或骨祖细胞。 在一个实施方案中,干细胞或祖细胞是多能的。

    SYNTHETIC TRITERPENOIDS AND METHODS FOR MODULATING STEM/PROGENITOR CELL GENE EXPRESSION
    33.
    发明申请
    SYNTHETIC TRITERPENOIDS AND METHODS FOR MODULATING STEM/PROGENITOR CELL GENE EXPRESSION 有权
    合成三磷酸酯和调节干细胞/原核细胞基因表达的方法

    公开(公告)号:US20150104429A1

    公开(公告)日:2015-04-16

    申请号:US14395157

    申请日:2013-05-07

    摘要: Synthetic triterpenoids and methods of using the same to induce gene expression and differentiation of stem or progenitor cells are provided. Furthermore, the present invention provides methods for producing a cell, such as a stem or progenitor cell, with induced gene expression by contacting a stem or progenitor cell with an effective amount of a synthetic triterpenoid to induce the expression of one or more of SOX9 (Sex determining region Y-box 9), COL2A1 (Type II Collagen (alpha1)), TGF-βI, TGF-p2, TGF-33, BMP2, BMP4, BMPRII (Bone Morphogenic Protein Receptor II), SMAD (Small Mothers Against Decapentaplegic) 3, SMAD4, SMAD6, SMAD7, TIMP (Tissue Inhibitor of Metalloproteinase)-1 or TIMP-2 in the stem or progenitor cell, wherein the stem or progenitor cell is not a mesenchymal stem cell, periosteium cell or osteoprogenitor cell. In one embodiment, the stem or progenitor cell is multipotent.

    摘要翻译: 提供合成三萜类化合物及其使用方法诱导干细胞或祖细胞的基因表达和分化。 此外,本发明提供了通过使干细胞或祖细胞与有效量的合成三萜化合物接触以诱导一种或多种SOX9的表达来生产具有诱导的基因表达的细胞例如干细胞或祖细胞的方法( 性别确定区域Y盒9),COL2A1(II型胶原(α1)),TGF-和bgr I,TGF-p2,TGF-β3,BMP2,BMP4,BMPRII(骨形态发生蛋白受体II),SMAD 针对剔除性皮炎)3,SMAD4,SMAD6,SMAD7,TIMP(金属蛋白酶组织抑制剂)-1或TIMP-2在茎或​​祖细胞中,其中干细胞或祖细胞不是间充质干细胞,骨膜细胞或骨祖细胞。 在一个实施方案中,干细胞或祖细胞是多能的。

    Sulphur containing lipids for use as food supplement or as medicament
    34.
    发明授权
    Sulphur containing lipids for use as food supplement or as medicament 有权
    含硫脂质用作食品补充剂或药物

    公开(公告)号:US08759558B2

    公开(公告)日:2014-06-24

    申请号:US13054212

    申请日:2009-07-13

    IPC分类号: C11D1/28 A61K31/10

    摘要: The present invention relates to lipid compounds of the general formula (I): wherein R1 is selected from a C10-C22 alkyl, a C10-C22 alkenyl having 1-6 double bonds, and a C10-C22alkynyl having 1-6 triple bonds; R2 and R3 are the same or different and may be selected from a group of different substituents; Y is selected from sulphur, sulfoxide, and sulfone; and X represents a carboxylic acid or a derivative thereof, a carboxylic ester, a carboxylic anhydride or a carboxamide; or a pharmaceutically acceptable salt, complex or solvate thereof.The invention also relates to pharmaceutical compositions and lipid compositions comprising such compounds, and to such compounds for use as medicaments or for use in therapy, in particular for the treatment of diseases related to the cardiovascular, metabolic and inflammatory disease area.

    摘要翻译: 本发明涉及通式(I)的脂质化合物:其中R1选自C10-C22烷基,具有1-6个双键的C10-C22烯基和具有1-6个三键的C10-C22炔基; R2和R3相同或不同,并且可以选自不同取代基的一组; Y选自硫,亚砜和砜; X表示羧酸或其衍生物,羧酸酯,羧酸酐或羧酰胺; 或其药学上可接受的盐,复合物或溶剂合物。 本发明还涉及包含这种化合物的药物组合物和脂质组合物,以及用作药物或用于治疗,特别是用于治疗与心血管,代谢和炎性疾病区域有关的疾病的化合物。